Top-News
Verkauf, spezialisiert USA

Viewray News

Aktie
WKN:  A2AE2S ISIN:  US92672L1070 US-Symbol:  VRAYQ
-   $
+0,00 $
0,00%
10.05.24 17:16:51
Handeln Depot/Watchlist
Aktienanzahl *
183,40 Mio.
Marktkapitalisierung *
170 €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 19.07.2023

Viewray News

21.07.23 - PR Newswire
ViewRay® Announces Commencement of Nasdaq Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Markets
ViewRay® Announces Commencement of Nasdaq Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Markets PR Newswire
17.07.23 - PR Newswire
ViewRay® Files Voluntary Chapter 11 Petitions
ViewRay® Files Voluntary Chapter 11 Petitions PR Newswire
13.06.23 - PR Newswire
VA Oklahoma City Healthcare System Chooses ViewRay's MRIdian® MRI-Guided Radiation Therapy System
VA Oklahoma City Healthcare System Chooses ViewRay's MRIdian® MRI-​Guided Radiation Therapy System PR Newswire
12.05.23 - PR Newswire
ViewRay's MRIdian® to be Featured at Leading European Radiation Oncology Meeting
ViewRay's MRIdian® to be Featured at Leading European Radiation Oncology Meeting PR Newswire
10.05.23 - PR Newswire
ViewRay Announces First Quarter 2023 Results
ViewRay Announces First Quarter 2023 Results PR Newswire
09.05.23 - PR Newswire
ViewRay Announces Conference Call for First Quarter 2023 Financial Results to be Held After Market on May 10, 2023
ViewRay Announces Conference Call for First Quarter 2023 Financial Results to be Held After Market on May 10, 2023 PR Newswire
13.04.23 - PR Newswire
ViewRay Announces Preliminary First Quarter 2023 Results and Updated Fiscal Year 2023 Financial Guidance; Company to Explore Strategic Alternatives to Maximize Shareholder Value
ViewRay Announces Preliminary First Quarter 2023 Results and Updated Fiscal Year 2023 Financial Guidance; Company to Explore Strategic Alternatives to Maximize Shareholder ...
12.04.23 - PR Newswire
ViewRay Announces Conference Call for Preliminary First Quarter 2023 Financial Results to be held Pre-Market opening on April 13, 2023
ViewRay Announces Conference Call for Preliminary First Quarter 2023 Financial Results to be held Pre-​Market opening on April 13, 2023 PR Newswire
07.03.23 - PR Newswire
Military University Hospital Prague Selects ViewRay's MRIdian® MRI-Guided Radiation Therapy System to Treat Cancer Patients
Military University Hospital Prague Selects ViewRay's MRIdian® MRI-​Guided Radiation Therapy System to Treat Cancer Patients PR Newswire
02.03.23 - PR Newswire
Siteman Cancer Center at Washington University Treats 2,000th Patient with MRIdian® MRI-Guided Radiation Therapy
Siteman Cancer Center at Washington University Treats 2,000th Patient with MRIdian® MRI-​Guided Radiation Therapy PR Newswire
27.02.23 - PR Newswire
ViewRay Announces Fourth Quarter and Full Year 2022 Results
ViewRay Announces Fourth Quarter and Full Year 2022 Results PR Newswire
31.01.23 - PR Newswire
ViewRay Announces Conference Call for Fourth Quarter 2022 Financial Results to be Held After Market on February 27, 2023
ViewRay Announces Conference Call for Fourth Quarter 2022 Financial Results to be Held After Market on February 27, 2023 PR Newswire
20.01.23 - PR Newswire
ViewRay Enters into Cooperation Agreement with Hudson Executive Capital
ViewRay Enters into Cooperation Agreement with Hudson Executive Capital PR Newswire
12.01.23 - PR Newswire
Findings Published in JAMA Oncology Demonstrate Superiority of MRIdian® MRI-Guidance in Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer
Findings Published in JAMA Oncology Demonstrate Superiority of MRIdian® MRI-​Guidance in Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer PR Newswire
09.01.23 - PR Newswire
ViewRay Announces Preliminary Fourth Quarter and Full Year 2022 Results; appoints William P. "Bill" Burke as Chief Financial Officer
ViewRay Announces Preliminary Fourth Quarter and Full Year 2022 Results; appoints William P. "Bill" Burke as Chief Financial Officer PR Newswire
05.01.23 - PR Newswire
Chindex Medical Acquires 10 ViewRay MRIdian® Systems for Advanced Cancer Treatment
Chindex Medical Acquires 10 ViewRay MRIdian® Systems for Advanced Cancer Treatment PR Newswire
05.01.23 - PR Newswire
University Hospitals in Cleveland Enters into Master Purchase Agreement with ViewRay for Multiple MRIdian® Systems
University Hospitals in Cleveland Enters into Master Purchase Agreement with ViewRay for Multiple MRIdian® Systems PR Newswire
14.11.22 - PR Newswire
ViewRay Expands Access to Non-Dilutive Capital With New Debt Facility
ViewRay Expands Access to Non-​Dilutive Capital With New Debt Facility PR Newswire
14.11.22 - PR Newswire
ViewRay® to Participate in the 34th Annual Piper Sandler Healthcare Conference
ViewRay® to Participate in the 34th Annual Piper Sandler Healthcare Conference PR Newswire
10.11.22 - PR Newswire
ViewRay® to Present at the Stifel 2022 Healthcare Conference
ViewRay® to Present at the Stifel 2022 Healthcare Conference PR Newswire

Newssuche

Videos

newspaper
07.05.24 +6,80%
Technical Trading: DAX Long kurzfristig
DAX Long Typ: Turbo Open End WKN: NG8K9X Hebel: 26 Laufzeit: OpenEnd Einstieg: Market ... Mehr »